Plantem BCR-ABL Deprehensio pro CML curatio

Longos myelogenousleukemia (CML) est maligna clonal morbo hematopoietic caule cellulis. Plus quam XCV% of CML aegris portare Philadelphia chromosoma (PH) in sanguine cellulis. Et BCR-ABL eget gene formatur per translocacionem inter ABL proto-oncogene (Abason Murine Leukemia virales Oncene Homolog I) in longum brachium chromosomos IX (9Q34) et breakpoint botri regionis (bcr) et breakpoint botter regione De Chromosomate XXII (22Q11). Et fusion dapibus encoded per hoc gene habet Tyrosine Kinase (tk) operatio, et operatur downstream signalling truci (ut ras, pi3k et inhibere cellula apoptosis, faciens cellulis et inhibere inhibere cellula, faciens cellulis et inhibere et inhibere cellulis, faciens cellulis et inhibere et inhibere, faciens cellulis et inhibere et inhibe Eventum CML.

BCR-ABL FUSIO Gene, quod est momenti in progressionem CML, serves ut a key diagnostic titulum CML. Et deprehendatur adjuvat ad Monitor patientes`Response to Tyrosine Kinase inhibitors (TKIS) et Predicts Leukemia recursu, quod est essentiale efficax CML patientes estote administratione.

Humanum BCR ABLFusion Gene Mutationem Deprehensio ornamentumEx Macro & Micro-test pro qualitatem deprehendatur BCR-ABL in CML aegroti, Assists CML diagnosi et ducibus targeted orci treatments ad optimize medicinales strategies ad effective patientes management.bcr-ABL eget Gene, quodestmaximusIn progressionem CML,Serves ut a key diagnostic titulumofCML. Et deprehensio iuvat admonitorpatiens`sRESPONSIO Tyrosine Kinase inhibitors (TKIS)etPredicts leukemia recursuQuod estnecessariusto efficaxCMLPatientes estote administratione.

Humanum BCR-ABL FUSIO Gene Mutationem Deprehensio ornamentum Ex Macro & Micro-test pro qualitatem deprehendatur in BCR-ABL in CML aegroti, adiuvatCMLdiagnosisetgramtargeted orci treatmentstoOptimizeCurationis Strategies ad efficax patientes administratione.

ComprehensivusDEtcion:Simultaneousdeprehensioenim3Common Fusion genes (P210, p190, p230)enimlata coverage etNe ex casibus desiderari;

High sensibility:Liquid version deprehendat eget genesEt LODde M copies / ml,et et lyophilized versionof D copies / ml;

PraeclarusACucceaty: Inudusimperiumet un enzyme ne falsum positivarum&negativis;

Facile operationem et efficientiam:Clausa-tubo operationem,productsPost-processus:etdeprehensiointusLX minutaenimObjective et reliable results;

MoreOptions:Liquid et lyophilized versions ad clients, optiones;

Wide Compatibility:Compatible cum maxime PCR systems ad wide Lab accessibility.